ClinicalTrials.Veeva

Menu

Fetal Heart Rate Pattern After Spinal Anesthesia for Scheduled Uncomplicated Cesarean Section

T

Taichung Veterans General Hospital

Status

Enrolling

Conditions

Continuous Fetal Heart Beat Monitor and Analysis After Spinal Anesthesia

Treatments

Drug: Spinal anesthesia with heavy bupivacaine

Study type

Observational

Funder types

Other

Identifiers

NCT05776186
CF22379A

Details and patient eligibility

About

Spinal anesthesia may cause sympathetic blockade which decrease peripheral vascular resistance and bradycardia and then hypotension. Maternal hypotension could cause immediate fetus heart beat (FHB) deceleration and postpartum acidosis. Both intravenous hydration or vasopressor during hypotension could prevent maternal hypotension efficiently. Although there were many articles discussion about maternal hypotension and fetal heart rate variation during epidural labor analgesia, the studies about FHB variation during spinal anesthesia is not much. In one literature in 1960, if maternal blood pressure below 60-80 mmHg, FHB deceleration could happen in 5 minutes. In modern medical management, FHB change during and after spinal anesthesia is an interesting topic. The most relevant study was published by NTUH in 2015, which transformed EKG signal to possible FHB change.

The parturient will have FHB recording for 20 minutes in the day before operation. On the operation day, after proper position by the anesthetic staff (lateral position or sitting position), spinal anesthesia will performed by obstetric anesthesiologist and the lying down for supine position. Before the baby was delivered by cesarean section no FHB will be monitored. The aim of the study is continuous FHB monitor and analysis after spinal anesthesia for 5-10 minutes to improve fetal physiology knowledge and providing basic information for future study.

Enrollment

50 estimated patients

Sex

Female

Ages

20 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Age above 20 years
  2. Singleton
  3. Gestational age above 36 weeks
  4. Scheduled Cesarean section at VGHTC
  5. Eligible for spinal anesthesia
  6. Inform consent

Exclusion criteria

  1. ASA > 3
  2. Prenatal examination reveal suspect neonatal congenital heart disease, heart failure, arrythymia or hydrops fetalis which could affect fetal heart beat
  3. Regular uterine contraction, premature rupture of membrane or vaginal bleeding before scheduled C/S on prenatal clinic
  4. Anticipate vaginal delivery initially but shift to C/S for prolong labor, FHB deceleration or other reason
  5. Patients cannot make decision for language barrier, education condition or phsycological disease
  6. Register in other study already

Trial design

50 participants in 2 patient groups

Before spinal anesthesia
Description:
Before spinal anesthesia with heavy bupivacaine 12.5 mg is administrated.
Treatment:
Drug: Spinal anesthesia with heavy bupivacaine
After spinal anesthesia
Description:
After spinal anesthesia with heavy bupivacaine 12.5 mg is administrated.
Treatment:
Drug: Spinal anesthesia with heavy bupivacaine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems